期刊文献+

甲状腺激素、皮质醇水平变化与脓毒症患者预后的相关性研究 被引量:6

Relationship between Serum Levels of Thyroid Hormones、Cortisoland Prognosis in Sepsis Patients
原文传递
导出
摘要 目的探讨血清甲状腺激素、皮质醇水平变化对脓毒症患者预后的影响。方法对54例脓毒症患者、30例非脓毒症患者血清游离甲碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺激素(TSH)含量及血清皮质醇(COR)浓度进行对照分析,并对脓毒症生存和死亡患者的甲状腺激素水平和COR水平与APACHEII评分的相关性进行分析。结果与非脓毒症组比较,脓毒症患者COR水平明显增高,而甲状腺激素水平明显降低。脓毒症死亡组COR水平明显高于生存组,而甲状腺激素水平明显降低。脓毒症患者APACHEII评分与血清COR水平呈显著正相关,而与FT3、FT4呈显著负相关(均P<0.05)。结论血清甲状腺激素、COR水平在一定程度上可反映脓毒症疾病的严重程度,可作为评价脓毒症患者预后的指标。 Objective To explore the relationship between serum levels of thyroid hormones, cortisol and prognosis in sepsis patients. Methods Total 54 sepsis patients and 30 non - sepsis patients were collected. The acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ )score, free T3 ( FT3 ) , free T4 ( FT4 ) , thyroid stimulating hormone ( TSH ) and cortisol ( COR ) were detected with cross - check analysis. The APACHE Ⅱscore, serum levels of thyroid hormones and COR in sepsis patients were detected with correlation analysis. Results Contrast with non - sepsis patients, in sepsis patients the levels of COR were obviously higher, the levels of thyroid hormones were obviously lower. In the fatality group, the levels of COR were obviously higher than that of the survival group, but the levels of thyroid hormones were obviously lower. There was obviously positive correlation between APACHE Ⅱ score and COR, but negative correlation between FF3 ,FT4 and APACHE Ⅱ score( all P 〈 0. 05 ). Conclusion The levels of thyroid hormones and COR can reflect the severity of sepsis, and can be refered to evaluating the prognosis of sepsis patients.
出处 《医药论坛杂志》 2010年第19期60-61,64,共3页 Journal of Medical Forum
关键词 脓毒症 甲状腺激素 皮质醇 预后 Sepsis Thyroid hormones Cortisol Prognosis
  • 相关文献

参考文献1

二级参考文献17

  • 1白耀.甲状腺疾病学[M].北京:科技文献出版社,2003.349.
  • 2Umpierrez GE. Euthyroid sick syndrome. South Med J, 2002, 95 ( 5 ):506-513.
  • 3Klemperer JD. Thyroid hormone and cardiac surgery. Thyroid, 2002, 12 (6): 517-521.
  • 4Beigneux AP, Moser AH, Shigenaga JK, et al. Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver.Am J Physiol Endocrinol Metab, 2003, 284 ( 1 ): E228-E236.
  • 5Cerillo. Nonthyroidal illness syndrome in off-pump coronary bypass grafting.Ann Thorac Surg, 2003, 75 (10): 892-897.
  • 6Palugniok R, Kochanska-Dziurowicz AA. Euthyroid sick syndrome in head injury patients compared with glasgow coma and outcome scales. Nucl Med Rev Cent East Eur, 2000, 3 (1): 13-16.
  • 7Shanoudy H, Soliman A, Moe S, et al. Early manifestations of "sick euthyroid" syndrome in patients with compensated chronic heart failure. J Card Fail, 2001, 7 (2): 146-152.
  • 8Pavlou HN, Kliridis PA, Panagiotopoulos AA, et al. Euthyroid sick syndrome in acute ischemic syndromes. Angiology, 2002, 53 (6): 699-707.
  • 9Lee WY, Kang MI, Oh KW, et al. Relationship between circulating cytokine levels and thyroid function following bone marrow transplantation. Bone Marrow Transplant, 2004, 33 (1): 93-98.
  • 10Lee WY, Suh JY, Kim SW, et al.Circulating IL-8 and IL-10 in euthyroid sick syndromes following bone marrow transplantation. J Korean Med Sci,2002, 17 (6): 755-760.

共引文献31

同被引文献41

  • 1谢丹红.正常甲状腺病态综合征研究进展[J].新医学,2005,36(4):245-247. 被引量:32
  • 2包子予,茅尧生.脓毒症患者甲状腺激素水平变化与预后的关系[J].实用医学杂志,2007,23(9):1327-1329. 被引量:4
  • 3WartofskyL, Burman KD. Aherations in thyroid function in patients with systemic illness, the " euthyroid sick syndrome" [ J]. Endocr Rev, 1982,3 ( 2 ) : 164-217.
  • 4Wrede CE. Endocrine regulation in critically ill patients [ J ]. DtschMed Wochenschr,2010,135(14) :712-715.
  • 5Woolf PD, Lee LA, Hamill RW, et al. Thyroid test abnormalities in traumatic brain injury: cmTelation with neurologic impairment and sympathetic nervous system activation [ J]. Am J Med, 1988,84 (2) :201-208.
  • 6Jarek MJ,Legare E J, McDermott MT, et al. Endocrine profiles for outcome prediction from the intensive care unit [ J]. Crit Care Med,1993,21 (4) :543-550.
  • 7Chopra I J, Solomon DH,Teco GN, et al. An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues [ J]. Science, 1982,215 (4531 ) :407-409.
  • 8Sumita S, Ujike Y, Namiki A, et al. Suppression of the thyrotropin response to thyrotropin-releasing hormone and its association with severity of critical illness [J]. Crit Care Med, 1994,22 ( 10 ) : 1603-1609.
  • 9Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration [ J ]. J Clin Endocrinol Metab, 1986,63 ( 1 ) : 1-8.
  • 10Dulawa A, BuLldak L, Krysiak R, et al. Hormonal supplementation in endocrine dysfunction in critically ill patient [ J]. PharnTacol Rep,2007,59 (2) :139-149.

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部